North America Genital Herpes Treatment Market 2022-2032 by Virus Type (HSV-1, HSV-2), Drug Type (Acyclovir, Valacyclovir, Famciclovir, Others), Route of Administration (Oral, Topical, Injection), Patient Gender (Female, Male), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Drug Stores), and Country: Trend Forecast and Growth Opportunity
North America genital herpes treatment market is projected to grow by 3.9% annually in the forecast period and reach $1,650.9 million by 2032
- Bonafide Trust
- 28-02-2023
- Pages : 107
- Figures : 44
- Tables : 25
- Region : North America
- Category : Lifescience
- Medical Devices
North America genital herpes treatment market is projected to grow by 3.9% annually in the forecast period and reach $1,650.9 million by 2032, driven by the rising prevalence of sexually transmitted diseases, changing socio-cultural openness, increasing awareness about HSV infection and its symptoms, improved access to antiviral medications, and the government supports. Highlighted with 25 tables and 44 figures, this 107-page report “North America Genital Herpes Treatment Market 2022-2032 by Virus Type (HSV-1, HSV-2), Drug Type (Acyclovir, Valacyclovir, Famciclovir, Others), Route of Administration (Oral, Topical, Injection), Patient Gender (Female, Male), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Drug Stores), and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire North America genital herpes treatment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America genital herpes treatment market in every aspect of the classification from perspectives Virus, Drug Type, Route of Administration, Patient Gender, Distribution Channel, and Country.
What's Inside a Bonafide Research`s industry report?
Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally
Download SampleBased on Virus Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section. • HSV-1 • HSV-2 Based on Drug Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section. • Acyclovir • Valacyclovir • Famciclovir • Other Drugs By Route of Administration, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section. • Oral • Topical • Injection
By Patient Gender, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section. • Female • Male By Distribution Channel, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section. • Retail Pharmacies • Hospital Pharmacies • Online Pharmacies • Drug Stores Geographically, the following national/local markets are fully investigated: • U.S. • Canada • Mexico For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Virus Type, Drug Type and Distribution Channel over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Abbott ADLEY FORMULATIONS Aurobindo Pharma Ltd. Avet Pharmaceuticals Inc. Bausch Health Companies Centurion Remedies Cipla Ltd. Eli Lilly & Company Finecure Pharmaceuticals GlaxoSmithKline Plc Glenmark Pharmaceuticals Macleods Pharmaceuticals Medico Remedies Merck & Co., Inc. Novartis AG Pfizer Reddy's Laboratories Sanofi SA Teva Pharmaceutical Industries Ltd. Torrent Pharma Viatris Inc. Zeelab Pharmacy Zydus Pharmaceuticals, Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents
- 1 Introduction 7
- 1.1 Industry Definition and Research Scope 7
- 1.1.1 Industry Definition 7
- 1.1.2 Research Scope 8
- 1.2 Research Methodology 11
- 1.2.1 Overview of Market Research Methodology 11
- 1.2.2 Market Assumption 12
- 1.2.3 Secondary Data 12
- 1.2.4 Primary Data 12
- 1.2.5 Data Filtration and Model Design 13
- 1.2.6 Market Size/Share Estimation 14
- 1.2.7 Research Limitations 15
- 1.3 Executive Summary 16
- 2 Market Overview and Dynamics 19
- 2.1 Market Size and Forecast 19
- 2.1.1 Impact of COVID-19 on World Economy 20
- 2.1.2 Impact of COVID-19 on the Market 23
- 2.2 Major Growth Drivers 25
- 2.3 Market Restraints and Challenges 29
- 2.4 Emerging Opportunities and Market Trends 32
- 2.5 Porter’s Fiver Forces Analysis 36
- 3 Segmentation of North America Market by Virus Type 40
- 3.1 Market Overview by Virus Type 40
- 3.2 HSV-1 42
- 3.3 HSV-2 43
- 4 Segmentation of North America Market by Drug Type 44
- 4.1 Market Overview by Drug Type 44
- 4.2 Acyclovir 47
- 4.3 Valacyclovir 48
- 4.4 Famciclovir 49
- 4.5 Other Drugs 50
- 5 Segmentation of North America Market by Route of Administration 52
- 5.1 Market Overview by Route of Administration 52
- 5.2 Oral 54
- 5.3 Topical 55
- 5.4 Injection 56
- 6 Segmentation of North America Market by Patient Gender 57
- 6.1 Market Overview by Patient Gender 57
- 6.2 Female 59
- 6.3 Male 60
- 7 Segmentation of North America Market by Distribution Channel 61
- 7.1 Market Overview by Distribution Channel 61
- 7.2 Retail Pharmacies 63
- 7.3 Hospital Pharmacies 64
- 7.4 Online Pharmacies 65
- 7.5 Drug Stores 66
- 8 North America Market 2022-2032 by Country 67
- 8.1 Overview of North America Market 67
- 8.2 U.S. 70
- 8.3 Canada 75
- 8.4 Mexico 77
- 9 Competitive Landscape 79
- 9.1 Overview of Key Vendors 79
- 9.2 New Product Launch, Partnership, Investment, and M&A 82
- 9.3 Company Profiles 83
- Abbott 83
- ADLEY FORMULATIONS 85
- Aurobindo Pharma Ltd. 86
- Avet Pharmaceuticals Inc. 87
- Bausch Health Companies 88
- Centurion Remedies 89
- Cipla Ltd. 90
- Eli Lilly & Company 91
- Finecure Pharmaceuticals 92
- GlaxoSmithKline Plc 93
- Glenmark Pharmaceuticals 94
- Macleods Pharmaceuticals 95
- Medico Remedies 96
- Merck & Co., Inc. 97
- Novartis AG 98
- Pfizer 99
- Reddy's Laboratories 100
- Sanofi SA 101
- Teva Pharmaceutical Industries Ltd. 102
- Torrent Pharma 103
- Viatris Inc. 104
- Zeelab Pharmacy 105
- Zydus Pharmaceuticals, Inc. 106
- RELATED REPORTS 107
Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032 16
Figure 4. North America Genital Herpes Treatment Market, 2022-2032, $ mn 19
Figure 5. Impact of COVID-19 on Business 23
Figure 6. Primary Drivers and Impact Factors of North America Genital Herpes Treatment Market 25
Figure 7. Forecast of Middle-class Population by Region, 2015-2030, million 28
Figure 8. Primary Restraints and Impact Factors of North America Genital Herpes Treatment Market 29
Figure 9. Investment Opportunity Analysis 33
Figure 10. Porter’s Fiver Forces Analysis of North America Genital Herpes Treatment Market 36
Figure 11. Breakdown of North America Genital Herpes Treatment Market by Virus Type, 2022-2032, % of Revenue 41
Figure 12. North America Addressable Market Cap in 2023-2032 by Virus Type, Value ($ mn) and Share (%) 41
Figure 13. North America Genital Herpes Treatment Market by Virus Type: HSV-1, 2022-2032, $ mn 42
Figure 14. North America Genital Herpes Treatment Market by Virus Type: HSV-2, 2022-2032, $ mn 43
Figure 15. Breakdown of North America Genital Herpes Treatment Market by Drug Type, 2022-2032, % of Sales Revenue 45
Figure 16. North America Addressable Market Cap in 2023-2032 by Drug Type, Value ($ mn) and Share (%) 45
Figure 17. North America Genital Herpes Treatment Market by Drug Type: Acyclovir, 2022-2032, $ mn 47
Figure 18. North America Genital Herpes Treatment Market by Drug Type: Valacyclovir, 2022-2032, $ mn 48
Figure 19. North America Genital Herpes Treatment Market by Drug Type: Famciclovir, 2022-2032, $ mn 49
Figure 20. North America Genital Herpes Treatment Market by Drug Type: Other Drugs, 2022-2032, $ mn 50
Figure 21. Breakdown of North America Genital Herpes Treatment Market by Route of Administration, 2022-2032, % of Sales Revenue 53
Figure 22. North America Addressable Market Cap in 2023-2032 by Route of Administration, Value ($ mn) and Share (%) 53
Figure 23. North America Genital Herpes Treatment Market by Route of Administration: Oral, 2022-2032, $ mn 54
Figure 24. North America Genital Herpes Treatment Market by Route of Administration: Topical, 2022-2032, $ mn 55
Figure 25. North America Genital Herpes Treatment Market by Route of Administration: Injection, 2022-2032, $ mn 56
Figure 26. Breakdown of North America Genital Herpes Treatment Market by Patient Gender, 2022-2032, % of Revenue 58
Figure 27. North America Addressable Market Cap in 2023-2032 by Patient Gender, Value ($ mn) and Share (%) 58
Figure 28. North America Genital Herpes Treatment Market by Patient Gender: Female, 2022-2032, $ mn 59
Figure 29. North America Genital Herpes Treatment Market by Patient Gender: Male, 2022-2032, $ mn 60
Figure 30. Breakdown of North America Genital Herpes Treatment Market by Distribution Channel, 2022-2032, % of Revenue 62
Figure 31. North America Addressable Market Cap in 2023-2032 by Distribution Channel, Value ($ mn) and Share (%) 62
Figure 32. North America Genital Herpes Treatment Market by Distribution Channel: Retail Pharmacies, 2022-2032, $ mn 63
Figure 33. North America Genital Herpes Treatment Market by Distribution Channel: Hospital Pharmacies, 2022-2032, $ mn 64
Figure 34. North America Genital Herpes Treatment Market by Distribution Channel: Online Pharmacies, 2022-2032, $ mn 65
Figure 35. North America Genital Herpes Treatment Market by Distribution Channel: Drug Stores, 2022-2032, $ mn 66
Figure 36. Breakdown of North America Genital Herpes Treatment Market by Country, 2022 and 2032, % of Revenue 68
Figure 37. Contribution to North America 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%) 69
Figure 38. Percentage of LGBT in Total Population in U.S., 2012-2021 71
Figure 39. Estimated Number of New (Incident) and Existing (Prevalent) Sexually Transmitted Infections in U.S. in 2018 72
Figure 40. Healthcare Cost by STI Type in U.S. in 2018 73
Figure 41. U.S. Genital Herpes Treatment Market, 2022-2032, $ mn 73
Figure 42. Canada Genital Herpes Treatment Market, 2022-2032, $ mn 75
Figure 43. Genital Herpes Treatment Market in Mexico, 2022-2032, $ mn 77
Figure 44. Growth Stage of North America Genital Herpes Treatment Industry over the Forecast Period 79
Table 1. Snapshot of North America Genital Herpes Treatment Market in Balanced Perspective, 2022-2032 17
Table 2. World Economic Outlook, 2021-2031 21
Table 3. World Economic Outlook, 2021-2023 22
Table 4. World Health Spending by Region, $ bn, 2013-2020 28
Table 5. Main Product Trends and Market Opportunities in North America Genital Herpes Treatment Market 32
Table 6. North America Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn 40
Table 7. North America Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn 44
Table 8. Side Effects of Genital Herpes Medications 44
Table 9. Vaccine Pipelines for Herpes 51
Table 10. North America Genital Herpes Treatment Market by Route of Administration, 2022-2032, $ mn 52
Table 11. North America Genital Herpes Treatment Market by Patient Gender, 2022-2032, $ mn 57
Table 12. North America Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn 61
Table 13. North America Genital Herpes Treatment Market by Country, 2022-2032, $ mn 68
Table 14. U.S. Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn 74
Table 15. U.S. Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn 74
Table 16. U.S. Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn 74
Table 17. Canada Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn 76
Table 18. Canada Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn 76
Table 19. Canada Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn 76
Table 20. Mexico Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn 78
Table 21. Mexico Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn 78
Table 22. Mexico Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn 78
Table 23. Abbott: Company Snapshot 83
Table 24. Abbott: Business Segmentation 84
Table 25. Abbott: Product Portfolio 84
Related Reports
Allows one individual to access the purchased report Read More
Allows all employees of an organization to access the purchased report. Internal sharing only Read More
Allows all employees of an organization to access the purchased report. It also permits the use of up to 4 paragraphs or 1 page of the report externally in whitepapers, press releases, and marketing collateral Read More
Safe and Secure SSL Encrypted
Quick Contacts
Want to customize this report?
We offer 10% Free Customization at the time of purchase
Get Free Customization
Trusted Partners
Budget constraints? Get in touch with us for special pricing
Request DiscountOrder Detail
- Order Placed (27 July, 2024)
- Notify To Team (27 July, 2024)
- Report updation (28 July, 2024)
- Report Quality Check (28 July, 2024)
- Report Dispatch (29 July, 2024)
- Hard Copy
Recently Viewed Products
North America Genital Herpes Treatment Market 2022-2032 by Virus Type (HSV-1, HSV-2), Drug Type (Acyclovir, Valacyclovir, Famciclovir, Others), Route of Administration (Oral, Topical, Injection), Patient Gender (Female, Male), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Drug Stores), and Country: Trend Forecast and Growth Opportunity
We are friendly and approachable, give us a call.